Publications by authors named "Janakiraman Subramanian"

47Publications

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib.

Semin Oncol 2019 06 11;46(3):271-283. Epub 2019 Sep 11.

Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO; Center for Precision Oncology, Saint Luke's Cancer Institute, Kansas City, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.08.004DOI Listing
June 2019

Emergence of Mutation as a Biomarker and an Actionable Target in Solid Cancers.

Oncologist 2019 12 10;24(12):e1303-e1314. Epub 2019 Jul 10.

Molecular Medicine and Therapeutics Laboratory, Centre for Plant Molecular Biology, Osmania University, Hyderabad, India

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975965PMC
December 2019

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

Expert Rev Anticancer Ther 2019 07 14;19(7):547-559. Epub 2019 Jun 14.

a Department of Medicine , University of Missouri Kansas City , Kansas City , MO , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1596030DOI Listing
July 2019

The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.

J Thorac Oncol 2018 05 31;13(5):707-714. Epub 2018 Jan 31.

Department of Medicine/Division of Hematology and Oncology, University of Missouri Kansas City, Kansas City, Missouri; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.01.019DOI Listing
May 2018

Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.

Semin Cancer Biol 2019 02 22;54:14-28. Epub 2017 Nov 22.

Department of Medicine, University of Missouri Kansas City School of Medicine, Kansas City, MO 64108, USA; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA; Center for Precision Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.11.016DOI Listing
February 2019

Predictors for chemotherapy in early stage small cell lung carcinoma (SCLC): A National Cancer Database (NCDB) analysis.

Lung Cancer 2017 11 13;113:85-87. Epub 2017 Sep 13.

Department of Medicine, University of Missouri, Kansas City, MO 64108, USA; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.09.004DOI Listing
November 2017

Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.

Clin Lung Cancer 2017 09 30;18(5):e315-e325. Epub 2017 Mar 30.

Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.003DOI Listing
September 2017

Genetic identification of marine eels through DNA barcoding from Parangipettai coastal waters.

Genom Data 2017 Mar 9;11:81-84. Epub 2016 Dec 9.

Centre of Advanced Study in Marine Biology, Faculty of Marine Sciences, Annamalai University, Tamil Nadu, India.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22135960163019
Publisher Site
http://dx.doi.org/10.1016/j.gdata.2016.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198627PMC
March 2017

DGIdb: mining the druggable genome.

Nat Methods 2013 Dec 13;10(12):1209-10. Epub 2013 Oct 13.

1] The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. [3].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nmeth.2689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851581PMC
December 2013

Molecular profile of lung cancer in never smokers.

EJC Suppl 2013 Sep;11(2):248-53

Washington University School of Medicine, Department of Medicine, St. Louis, USA ; Alvin J. Siteman Cancer Center at Washington University School of Medicine, St. Louis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcsup.2013.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041029PMC
September 2013

Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.

J Thorac Oncol 2012 Oct;7(10):1485-9

Department of Medicine, Division of Medical Oncology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318267223aDOI Listing
October 2012

A roundup of articles published in recent months.

J Thorac Oncol 2012 Mar;7(3):626-8

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153257
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e3182436098DOI Listing
March 2012

Optimising therapy for EGFR-addicted NSCLC: just the start.

Lancet Oncol 2012 Mar 26;13(3):216-7. Epub 2012 Jan 26.

Division of Oncology, Department of Medicine, and Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70037-2DOI Listing
March 2012

Recent advances in lung cancer: summary of presentations from the 47 th annual meeting of the American Society of Clinical Oncology (ASCO) 2011.

J Thorac Oncol 2012 Jan;7(1):260-5

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153178
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31823a40a6DOI Listing
January 2012

Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.

Clin Lung Cancer 2012 Mar 18;13(2):123-8. Epub 2011 Nov 18.

Section of Hematology and Oncology, Department of Medicine, and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.10.001DOI Listing
March 2012

Targeted therapy in lung cancer: lessons learned from past experiences.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1786-8

Division of Oncology, Department of Medicine, and Alvin J Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153263
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000407558.38416.c5DOI Listing
November 2011

Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.

Clin Lung Cancer 2011 Mar 8;12(2):94-9. Epub 2011 Apr 8.

Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.03.003DOI Listing
March 2011

Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.

J Thorac Oncol 2011 Feb;6(2):399-403

Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318200f972DOI Listing
February 2011

Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Clin Lung Cancer 2010 Sep;11(5):311-9

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2010.n.039DOI Listing
September 2010

Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.

J Thorac Oncol 2010 Aug;5(8):1116-9

Division of Oncology, Department of Medicine, Washington University School of Medicine, 660 S. Euclid, Box 8056, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181e76159DOI Listing
August 2010

Lung cancer in 'Never-smokers': a unique entity.

Oncology (Williston Park) 2010 Jan;24(1):29-35

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
January 2010

Chemotherapy: continued lack of progress in SCLC.

Nat Rev Clin Oncol 2010 Feb;7(2):77-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.223DOI Listing
February 2010

Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.

J Thorac Oncol 2009 Dec;4(12):1524-9

Division of Hematology-Oncology, St. Louis Veterans Hospital, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ba3634DOI Listing
December 2009

Small cell, big problem! Stem cells, root cause?

Clin Lung Cancer 2008 Sep;9(5):252-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.039DOI Listing
September 2008

Molecular genetics of lung cancer in people who have never smoked.

Lancet Oncol 2008 Jul;9(7):676-82

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70174-8DOI Listing
July 2008

Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).

J Thorac Oncol 2007 Sep;2(9):827-30

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641530871
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318145af79DOI Listing
September 2007

Lung cancer in never smokers: a review.

J Clin Oncol 2007 Feb;25(5):561-70

Department of Medicine and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.8015DOI Listing
February 2007

Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report.

Lung Cancer 2006 Feb 18;51(2):257-9. Epub 2006 Jan 18.

Department of Medicine, St Luke's Hospital, Chesterfield, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.10.007DOI Listing
February 2006